The largest database of trusted experimental protocols

Tnp atp triethylammonium salt

Manufactured by Bio-Techne
Sourced in United States

TNP-ATP triethylammonium salt is a laboratory reagent used in various biochemical and biophysical applications. This compound serves as a fluorescent ATP analog, allowing for the study of ATP-dependent processes and the detection of ATP-binding proteins. The triethylammonium salt formulation provides solubility in aqueous solutions.

Automatically generated - may contain errors

6 protocols using tnp atp triethylammonium salt

1

Pharmacological Manipulation of Neurochemicals

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following drugs were kept at −20°C as stock solutions and dissolved in aCSF to their final concentrations on the day of experiments: L-(−)-norepinephrine (+)-bitartrate salt monohydrate (NE, 10-100 μM, Sigma-Aldrich, shielded from light exposure during preparation, storage and application), picrotoxin (PTX, 50 μM, Tocris), prazosin hydrochloride (10 μM, Sigma-Aldrich), (R)-(−)-phenylephrine hydrochloride (100 μM, Sigma-Aldrich), yohimbine hydrochloride (20 μM, Tocris), tetrodotoxin (TTX, 1 μM, Tocris), TNP-ATP triethylammonium salt (10 μM, Tocris), pyridoxalphosphate-6-azophenyl-2′,4’-disulfonic acid tetrasodium salt (PPADS, 100 μM, Tocris).
Fluorocitric acid (FCA, Sigma-Aldrich) was prepared on the day of experiments with DL-fluorocitric acid barium salt (Paulsen et al., 1987 (link)) dissolved in 1 mL of 0.1 M HCl. Two-to-three drops of 0.1 M Na2SO4 was added to precipitate the Ba2+, after which 2 mL of 0.1 M Na2HPO4 was added and the suspension was centrifuged at 1000 g for 5 min. The supernatant was added to the aCSF to achieve a concentration of 100 μM.
+ Open protocol
+ Expand
2

Pharmacological inhibition of purinergic signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
EpiLife culture medium with Ca2+ (60 μM), EpiLife defined growth supplement (EDGS), penicillin/streptomycin, and Lipofectamine 2000 reagent were purchased from Thermo Fisher Scientific (Waltham, MA USA). On-target plus siRNA was purchased from GE healthcare (Little Chalfont, UK). FNC coating mixture was purchased from Athena ES (Baltimore, MA, USA). Suramin hexasodium salt (an inhibitor of P2X and P2Y receptors), PPADS tetrasodium salt (an inhibitor of P2X and P2Y receptors), TNP-ATP triethylammonium salt (an inhibitor of P2X receptor), NF 157 (an inhibitor of P2Y11 and P2X1), ARL 67156 (an inhibitor of ecto-ATPases), and 10Panx (an inhibitor of Pannexin-1 channel) were purchased from Tocris Bioscience (Minneapolis, MN, USA). Adenosine-5’-(γ-thio)-triphosphate tetralithium salt (ATPγS, a non-hydrolyzable ATP analogue), Brilliant blue G (BBG; an inhibitor of P2X receptors), and apyrase were purchased from Sigma-Aldrich (St. Louis, MO, USA).
+ Open protocol
+ Expand
3

Pharmacological Manipulation of Neurochemicals

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following drugs were kept at −20°C as stock solutions and dissolved in aCSF to their final concentrations on the day of experiments: L-(−)-norepinephrine (+)-bitartrate salt monohydrate (NE, 10-100 μM, Sigma-Aldrich, shielded from light exposure during preparation, storage and application), picrotoxin (PTX, 50 μM, Tocris), prazosin hydrochloride (10 μM, Sigma-Aldrich), (R)-(−)-phenylephrine hydrochloride (100 μM, Sigma-Aldrich), yohimbine hydrochloride (20 μM, Tocris), tetrodotoxin (TTX, 1 μM, Tocris), TNP-ATP triethylammonium salt (10 μM, Tocris), pyridoxalphosphate-6-azophenyl-2′,4’-disulfonic acid tetrasodium salt (PPADS, 100 μM, Tocris).
Fluorocitric acid (FCA, Sigma-Aldrich) was prepared on the day of experiments with DL-fluorocitric acid barium salt (Paulsen et al., 1987 (link)) dissolved in 1 mL of 0.1 M HCl. Two-to-three drops of 0.1 M Na2SO4 was added to precipitate the Ba2+, after which 2 mL of 0.1 M Na2HPO4 was added and the suspension was centrifuged at 1000 g for 5 min. The supernatant was added to the aCSF to achieve a concentration of 100 μM.
+ Open protocol
+ Expand
4

Expression and Purification of P2X Receptors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Unless otherwise stated, all compounds were purchased from Sigma-Aldrich (USA). TNP-ATP triethylammonium salt was purchased from Tocris bioscience (Catalog No.: 2464), with a purity of more than 98%. hP2X3 plasmid was purchased from Open Biosystems; ckP2X7 cDNA was a generous gift of Dr. Osamu Nureki and was subcloned into pcDNA3.1 vector; pcDNA3-rP2X2, pcDNA3-rP2X3 plasmids were generous gifts of Drs. Alan North and Linhua Jiang. All mutants were created using the KOD-Plus- mutagenesis kit (Toyobo, SMK-101) and confirmed by DNA sequencing [39] .
+ Open protocol
+ Expand
5

Pharmacological inhibition of purinergic signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
EpiLife culture medium with Ca2+ (60 μM), EpiLife defined growth supplement (EDGS), penicillin/streptomycin, and Lipofectamine 2000 reagent were purchased from Thermo Fisher Scientific (Waltham, MA USA). On-target plus siRNA was purchased from GE healthcare (Little Chalfont, UK). FNC coating mixture was purchased from Athena ES (Baltimore, MA, USA). Suramin hexasodium salt (an inhibitor of P2X and P2Y receptors), PPADS tetrasodium salt (an inhibitor of P2X and P2Y receptors), TNP-ATP triethylammonium salt (an inhibitor of P2X receptor), NF 157 (an inhibitor of P2Y11 and P2X1), ARL 67156 (an inhibitor of ecto-ATPases), and 10Panx (an inhibitor of Pannexin-1 channel) were purchased from Tocris Bioscience (Minneapolis, MN, USA). Adenosine-5’-(γ-thio)-triphosphate tetralithium salt (ATPγS, a non-hydrolyzable ATP analogue), Brilliant blue G (BBG; an inhibitor of P2X receptors), and apyrase were purchased from Sigma-Aldrich (St. Louis, MO, USA).
+ Open protocol
+ Expand
6

Fibronectin and Epigenetic Regulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fibronectin, 5-aza-2′-deoxycytidine, and TGFβ-1 humankineTM were purchased from Sigma. Collagen IV was purchased from Cultrex (Gaithersburg, MD). TNP-ATP triethylammonium salt was purchased from Tocris Bioscience (Bristol, UK).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!